Andrea Maier and NMN: study parameters, no outcomes yet
Andrea Maier, Oon Chiew Seng Professor in Medicine at the National University of Singapore, is linked to NMN through a study excerpt describing 80 middle-aged participants given 300, 600, or 900 mg daily for 60 days; her role and the study's outcomes are not established.
80 healthy middle-aged participants, 60 days, daily NMN at 300, 600, or 900 mg. This excerpt from our database links Andrea Maier to nicotinamide mononucleotide.
Andrea Maier holds the Oon Chiew Seng Professorship in Medicine at the National University of Singapore and co-founded its Academy for Healthy Longevity. Her work combines geroscience, clinical trials, and precision geromedicine. NMN is a precursor to NAD, used to increase NAD availability and support cellular energy metabolism.
The excerpt does not establish Maier's role in the described study, its title, publication venue, or trial design (randomization, blinding, control group). Dosing parameters are given; outcomes are not. The next step is locating the primary publication and confirming Maier's involvement.
High-confidence edge (0.99) between a named researcher and a named compound, grounded in a concrete human study description with specific numbers; the honest gap between design parameters and missing outcomes gives the reader a precise question to chase rather than a vague pattern to admire.